Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of Ciclopirox Shampoo in the US due to manufacturing issues, specifically "Failed Impurity Degradation specifications." The US Food and Drug Administration (USFDA) classified this as a Class II recall, indicating potential for temporary or medically reversible health consequences. The recall, initiated on December 9, affects a product used to treat seborrheic dermatitis. Sun Pharma fully acquired Taro last year.